Good morning. Happy Friday.
The Asian/Pacific markets leaned to the upside. Hong Kong, South Korea and Taiwan did well; Japan was weak. Europe, Africa and the Middle East currently lean to the upside. Turkey, Greece, South Africa, Russia, Italy, Israel and Saudi Arabia are doing well; Denmark is weak. Futures in the States point towards a positive open for the cash market.
—————
VIDEO: Current Trades
—————
The dollar is down. Bitcoin is up. Oil is down; copper is up. Gold and silver are up. Bonds are down.
Stock headlines from barchart.com…
Humana (HUM +0.80%) was upgraded to ‘Buy’ from ‘Hold’ at Jeffries with a price target of $333.
eBay (EBAY +0.29%) was upgraded to ‘Buy’ from ‘Hold’ at Suntrust Robinson Humphrey with a price target of $46.
JPMorgan Chase (JPM +0.54%) fell -0.5% in pre-market trading after it reported a -26% decline in Q4 trading revenue, a bigger decline than expectations of -19%.
Texas Roadhouse (TXRH +1.31%) was rated a new ‘Outperform’ at Wedbush with a 12-month target price of $67.
Finisar (FNSR +2.44%) gained 2% in after-hours trading after it announced the retirement of co-founder and CEO Jerry Rawls and appointment of Michael Hurlston as new CEO effective today.
Exact Sciences (EXAS +2.04%) fell over 5% in after-hours trading after it announced an underwritten public offering of $500 million in convertible senior notes due 2025.
Travelport Worldwide Ltd (TVPT -1.46%) climbed almost 4% in after-hours trading after it was named to replace Bob Evans in the S&P SmallCap 600 before the open of trading on Wednesday, Jan 17.
Astronics (ATRO +1.86%) rallied 5% in after-hours trading after it raised its 2018 consolidated revenue estimate to $745 million-$815 million from a prior view of $675 million-$750 million.
Taylor Morrison Home (TMHC +3.46%) dropped almost 3% in after-hours trading after it announced the commencement of an underwritten public offering of 19.2 million shares of its Class A common stock.
Advanced Micro Devices (AMD +1.51%) slid nearly 3% in after-hours trading after it acknowledged that two vulnerabilities apply to its chips after it said on Jan 3 that it sees “near zero risk” its chips were vulnerable to hacking.
Miragen Therapeutics (MGEN +0.35%) was rated a new ‘Outperform at Oppenheimer with an 18-month target price of $13.
Scorpio Bulkers (SALT -2.63%) was rated a new ‘Buy’ at Noble Financial Group with a 12-month target price of $10.
Aradigm (ARDM -7.57%) plunged 44% in after-hours trading after the FDA failed to approve Aradigm’s Linhaliq for treatment of non-cystic fibrosis bronchiectasis in patients with chronic lung pseudomonas aeruginosa infections.
Today’s Economic Calendar
8:30 Consumer Price Index
8:30 Retail Sales
10:00 Business Inventories
12:30 PM Fed’s Harker Speech
1:00 PM Baker-Hughes Rig Count
4:30 PM Fed’s Rosengren: “Money, Models, and Digital Innovation”
Other…
today’s upgrades/downgrades from briefing.com
this week’s Earnings from Morningstar
this week’s Economic Numbers/Reports powered by ECONODAY